|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA01170034
|
5Z,8Z,11Z,14Z-Eicosatetraenedioic acid
|
5Z,8Z,11Z,14Z-Eicosatetraenedioic acid
|
Fatty Acids and Conjugates [FA01]
|
Dicarboxylic acids [FA0117]
|
334.21
|
C20H30O4
|
|
LMFA03010033
|
13,14-dihydro-15-keto-PGA2
|
9,15-dioxo-5Z,10-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010051
|
15-deoxy-delta-12,14-PGD2
|
9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010092
|
15R-PGA2
|
9oxo-15R-hydroxy-5Z,10Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010100
|
5-trans-PGA2
|
9oxo-15S-hydroxy-5E,10Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010235
|
5E-PGB2
|
15S-hydroxy-9-oxo-5E,8(12),13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010035
|
PGA2
|
9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010018
|
PGB2
|
15S-hydroxy-9-oxo-5Z,8(12),13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010133
|
PGC2
|
9-oxo-15S-hydroxy-5Z,11Z,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010198
|
PGE2 1,15-lactone
|
9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010197
|
PGF3alpha-1,15-lactone
|
9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010019
|
PGJ2
|
11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010034
|
bicyclo-PGE2
|
9,15-dioxo-5Z-prostaenoic acid-cyclo[11S,16]
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03010020
|
delta-12-PGJ2
|
11-oxo-15S-hydroxy-5Z,9Z,12E-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
334.21
|
C20H30O4
|
|
LMFA03020024
|
12-oxo-LTB4
|
5S-hydroxy-12-keto-6Z,8E,10E,14Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
334.21
|
C20H30O4
|
|
LMFA03020017
|
14,15-dehydro-LTB4
|
5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
334.21
|
C20H30O4
|
|
LMFA03020069
|
5-Oxo-6-trans-leukotriene B4
|
(6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
334.21
|
C20H30O4
|
|
LMFA03020010
|
LTB5
|
5S,12S-dihydroxy-6Z,8E,14Z,17Z-eicosapentanenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
334.21
|
C20H30O4
|
|
LMFA03060117
|
14,15-epoxy,13-HETE
|
14,15-epoxy-13-hydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
334.21
|
C20H30O4
|
|
LMFA03060115
|
14,15-epoxy,16-HETE
|
14,15-epoxy-16-hydroxy-5Z,8Z,11Z,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
334.21
|
C20H30O4
|
|
LMFA03060075
|
5,6-Ep-15S-HETE
|
5S,6S-epoxy-15S-hydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
334.21
|
C20H30O4
|
|
LMFA03060116
|
8,9-epoxy,7-HETE
|
8,9-epoxy-7-hydroxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
334.21
|
C20H30O4
|
|
LMFA03070050
|
11,18-di-HEPE
|
11,18-dihydroxy-5Z,8Z,12E,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070051
|
12,18-di-HEPE
|
12,18-dihydroxy-5Z,8Z,10E,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070012
|
12S-HpEPE
|
12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070056
|
14-HpEPE
|
14-hydroperoxy-5Z,8Z,11Z,15E,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070013
|
15S-HpEPE
|
15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070043
|
18R-HpEPE
|
18R-hydroperoxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070059
|
5R-HpEPE
|
5R-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070001
|
5S-HpEPE
|
5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070052
|
8,18-di-HEPE
|
8,18-dihydroxy-5Z,9E,11Z,14Z,16E-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070061
|
9,15-diHEPE
|
9S,15S-dihydroxy-5Z,7E,11Z,13E,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070057
|
9S-HpEPE
|
9S-hydroperoxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03070060
|
|
12R,13R-dihydroxy-eicosa-5Z,8Z,10E,14Z,17Z-pentaenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307]
|
334.21
|
C20H30O4
|
|
LMFA03110263
|
11-epi-8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110282
|
11-epi-8-J2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5S)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110248
|
12-A2-IsoP
|
4-((1R,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110087
|
12-J2-IsoP
|
12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110247
|
12-epi-12-A2-IsoP
|
4-((1R,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110088
|
12-epi-12-J2-IsoP
|
12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110138
|
15-A2-IsoP
|
9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110101
|
15-J2-IsoP
|
15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110139
|
15-epi-15-A2-IsoP
|
9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110102
|
15-epi-15-J2-IsoP
|
15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110249
|
5,12-diepi-12-A2-IsoP
|
4-((1S,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110275
|
5,12-diepi-12-J2-IsoP
|
4-((1R,5S)-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110255
|
5,8-diepi-5-A2-IsoP
|
(R,E)-5-hydroxy-7-((1S,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110279
|
5,8-diepi-5-J2-IsoP
|
(R,E)-5-hydroxy-7-((S,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110257
|
5-A2-IsoP
|
(S,E)-5-hydroxy-7-((1R,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|
|
LMFA03110072
|
5-J2-IsoP
|
5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
334.21
|
C20H30O4
|